A comparison of haloperidol and thioridazine HC1 in chronic treatment-resistant schizophrenics.
D000328:Adult; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003210:Concept Formation; D006167:Guilt; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D012559:Schizophrenia / Q000188:drug therapy*; D013881:Thioridazine / Q000009:adverse effects / Q000627:therapeutic use*
D006220:Haloperidol; D013881:Thioridazine